In New York, within the walls of the French Consulate and The Rockefeller University, the 2025 edition of the French American Innovation Day (FAID) took place, organized by the Office for Science and Technology of the Embassy of France in the United States.

This event brought together key players from research, industry, and innovation to strengthen scientific and entrepreneurial collaborations between France and the United States in the field of health.

One of the highlights of the event was the startup pitch session, which showcased high-potential projects with strong public health impact. Marseille Immunology Biocluster (MIB) was represented by its CEO, Carole Masurier, who served as a member of a transatlantic jury.

As the only French biocluster dedicated to immunology, MIB promotes an integrated vision of biomedical research, focused on real-world impact for patients. Its participation in this event reflects its commitment to promoting French scientific excellence and building lasting bridges between European and North American innovation ecosystems.

FAID 2025 thus served as a platform to spotlight visionary entrepreneurs and bold approaches aligned with today’s global health challenges.